aod9604 wada status prohibited list Association WADA Prohibited List - Banned

Research Applications This selective activity makes AOD9604 an attractive candidate for obesity treatment and body composition optimization research, as it theoretically provides the metabolic benefits of growth hormone for fat reduction without the growth-promoting effects that could stimulate cancer cell proliferation, cause acromegaly-like symptoms, or induce insulin resistance

In diet-induced obese mice, JBSNF-000088 treatment reduced body weights, improved insulin sensitivity and normalized glucose tolerance [58]

Lai L, Wang M, Martin OJ, Leone TC, Vega RB, Han X, Kelly DP

Their body mass index was higher as well

Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet